Agreed Tony. Around the 28 min mark, Jon mentions that the P2 protocol will be discussed with the FDA following the end of Phase 2 meeting coming up in Q3 this year. Any NEW INDICATIONS identified by the currently underway pre-clinical trials would then hopefully move straight into Phase 2 trials under the re-negotiated/optimised protocol.
NEU Price at posting:
$23.12 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)